When the researchers further analyzed their results they found that only the women with hormone receptor positive breast cancers benefited from the adjuvant treatment. Dr. Hillner is conducting further analyses of different strategies based on these study results because of the major implications for public health policy in countries with limited economic resources. In discussing different standards of care in poorer and richer countries, Dr. Love and Dr. Nguyen Ba Duc, director of the National Cancer Institute in Hanoi, Vietnam, noted that the risks and benefits of the available treatment programs for breast cancer are much different in Vietnam and the United States. To date, drug hormone receptor tests on a regular basis are not yet possible in Vietnam. Dr. Love added that it is a moral requirement as well as a practical necessity that potential new cancer treatments in poorer countries be made available to the majority of patients who need them.
Many treatments are unavailable or too expensive for use in poor nations.
For many poorer women, these study results are very important. Xpress Press shall not be liable to any person or entity under any circumstances for any special, incidental, indirect or consequential damages, including, without limitation, damages resulting from use of or reliance on the information presented, loss of profits or revenues or costs of replacement goods, even if informed in advance of the possibility of such damages. Some jurisdictions do not allow the exclusion of implied warranties so the above exclusions may not apply to you. Entertainment Television, CNBC's Squawk Box, Fast Company Magazine, Family News service, Fox Market Wire, Life Magazine, PC Gaming, The Wall Street Journal Europe, Digital Business, Infhotel Press, Internet Marketing in Japan, and Woman's Day.